The United States on Saturday urgently approved un treatment with synthetic antibodies against Covid-19 of the Regeneron company, which was used to treat President Donald Trump when he contracted the coronavirus.

“It is possible to license these therapies with monoclonal antibodies help outpatients not to be hospitalized “and ease the burden on our health care system,” said Stephen Hahn, commissioner of the US Food and Drug Administration (FDA).

The drug is designed to prevent coronavirus sufferers from developing a serious illness, Infobae said. The medium adds that instead of waiting for the body to develop an immune response, the drug mimics the body’s natural defenses.

This would be second monoclonal drug, used to combat covid-19.

As the FDA pointed out after approving the antibody cocktail of the drug, which can be effective in treating the virus mild to moderate in adults and children 12 years and older. It will also be indicated for people at high risk of developing a serious illness.